Barbara Buldini

10PUBLICATIONS

160CO-AUTHORS

Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Infant and child healthMedical infection agents (incl. prions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jun 26, 2026

Plasticity under pressure: biology and detection of lineage switch in acute leukemia.

|Nov 10, 2025

Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009.

Hanna Gottschalk, Anja Möricke, Valentino Conter

|Jun 25, 2024

Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk.

Shunsuke Kimura, Chun Shik Park, Lindsey E Montefiori

|Jan 12, 2024

CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.

Barbara Buldini, Elena Varotto, Margarita Maurer-Granofszky

|Dec 14, 2023

Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.

Valentino Conter, Maria Grazia Valsecchi, Gunnar Cario

|Jul 24, 2023

Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials.

Elizabeth A Raetz, Paola Rebora, Valentino Conter

Pageof 2

Frequent Collaborators

Jan Stary

Martin Schrappe

Valentino Conter

Sarah Elitzur

Franco Locatelli

Andishe Attarbaschi

Michael N Dworzak

Riccardo Masetti

Kjeld Schmiegelow

Shai Izraeli

Frequent Collaborators

Jan Stary

Martin Schrappe

Valentino Conter

Sarah Elitzur